Sort   by:  
 Page size 
UnknownEffects of orally administered crofelemer on the incidence and severity of neratinib-induced diarrhea in female dogs.
Not available
S-EPMC10807780 | biostudies-literature
UnknownA single dose of zoledronate preserves bone mineral density for up to 2 years after a second course of romosozumab.
Not available
S-EPMC7560921 | biostudies-literature
UnknownCinacalcet HCl reduces hypercalcemia in primary hyperparathyroidism across a wide spectrum of disease severity.
Not available
S-EPMC3203649 | biostudies-literature
UnknownEfficacy and safety of elinzanetant, a selective neurokinin-1,3 receptor antagonist for vasomotor symptoms: a dose-finding clinical trial (SWITCH-1).
Not available
S-EPMC9970022 | biostudies-literature
UnknownRomosozumab Enhances Vertebral Bone Structure in Women With Low Bone Density.
Not available
S-EPMC9299688 | biostudies-literature
UnknownGlobal Differences in Risk Factors, Etiology, and Outcome of Ischemic Stroke in Young Adults-A Worldwide Meta-analysis: The GOAL Initiative.
Not available
S-EPMC8829964 | biostudies-literature
UnknownGlobal Outcome Assessment Life-long after stroke in young adults initiative-the GOAL initiative: study protocol and rationale of a multicentre retrospective individual patient data meta-analysis.
Not available
S-EPMC6887075 | biostudies-literature
UnknownCenter-Related Determinants of VKA Anticoagulation Quality: A Prospective, Multicenter Evaluation.
Not available
S-EPMC4670074 | biostudies-literature
UnknownSafety and Outcome of Revascularization Treatment in Patients With Acute Ischemic Stroke and COVID-19: The Global COVID-19 Stroke Registry.
Not available
S-EPMC9969910 | biostudies-literature
UnknownEarly responsiveness of women with osteoporosis to teriparatide after therapy with alendronate or risedronate.
Not available
S-EPMC5399468 | biostudies-literature
Sort   by:  
 Page size